InnoTherapy Inc.

Company Description

Biotech-Venture company specialized in high value R&D toolkit - Process Engineering Platform Technology based on CHO Cell Engineering (Recombinant cell line construction, Culture & process optimization, Efficient production)- Products: Angiogenesis, Antibody protein, High quality reagents for research (As a research tool for new drug development)Brief Historical Overview of InnoTherapy2010. 4 InnoTherapy Inc. found2010. 6 Technology Transfer Agreement from KAIST2010. 6 Venture Company approval from Korea government2010. 8 SEG Technology Development2010. 9 BIOKOREA2010 presentationVision1. Competitive Platform Technology (SEG etc.) 2. Profitable & Integrated New Business Model Development3. Globalization based on Patent Strategy

Company Information

  • Country/Region: Korea
  • Address: #821, Mario tower 222-12, Guro-dong, Guro-gu,, Seoul
  • Website: www.innotherapy.com
  • Business Type: Manufacturer
  • Main Products: Recombinant Protein, Angiogenesis, Angiogenic, Angiogenic Inhibitor, COMP-Ang1, COMP-Ang2, Ang1, Ang2, VEGF, DAAP, Angiopoietin, Ang, Comp,
  • Location: Seoul
  • Year Established: 2010
  • Number Of Employess: 1 - 5
  • Total Revenue: USD 1,000,001 - 2,000,000

Contact info

  • Contact Person: Jae Sook, Lee
  • Job Title: Staff
  • Telephone:
  • Mobilephone:
  • Fax Number:

Related Product

  • COMP-Angiopoietin1 (Human) (Rec.)
  • Angiopoietin1 (Human) (Rec.)
  • VEGF-trap (Human) (Rec.)

Relevant Companies